Your browser doesn't support javascript.
loading
Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemia.
Senapati, Jayastu; Urrutia, Samuel; Loghavi, Sanam; Short, Nicholas J; Issa, Ghayas C; Maiti, Abhishek; Abbas, Hussein A; Daver, Naval G; Pemmaraju, Naveen; Pierce, Sherry; Chien, Kelly S; Sasaki, Koji; Kadia, Tapan M; Hammond, Danielle E; Borthakur, Gautam; Patel, Keyur; Ravandi, Farhad; Kantarjian, Hagop M; Garcia-Manero, Guillermo; DiNardo, Courtney D.
  • Senapati J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Urrutia S; Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Maiti A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Abbas HA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Hammond DE; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Patel K; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Blood ; 142(19): 1647-1657, 2023 11 09.
Article en En | MEDLINE | ID: mdl-37441846
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Aged / Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Aged / Humans Idioma: En Año: 2023 Tipo del documento: Article